Virtus ETF Advisers LLC Mirati Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$27.8 - $45.35 $7,450 - $12,153	-268 Reduced 9.08%	2,684 $116,000
Q2 2023 Aug 14, 2023	BUY	$36.13 - $49.49 $22,906 - $31,376	634 Added 27.35%	2,952 $106,000
Q1 2023 May 15, 2023	SELL	$36.54 - $54.26 $32,337 - $48,020	-885 Reduced 27.63%	2,318 $86,000
Q4 2022 Feb 14, 2023	BUY	$41.27 - $98.62 $50,101 - $119,724	1,214 Added 61.04%	3,203 $145,000
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $833 - $1,213	14 Added 0.71%	1,989 $139,000
Q2 2022 Aug 12, 2022	BUY	$39.16 - $88.71 $33,716 - $76,379	861 Added 77.29%	1,975 $133,000
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $5,231 - $10,416	-69 Reduced 5.83%	1,114 $92,000
Q4 2021 Feb 14, 2022	SELL	$132.01 - $190.29 $8,712 - $12,559	-66 Reduced 5.28%	1,183 $174,000
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $9,116 - $12,244	-69 Reduced 5.24%	1,249 $221,000
Q2 2021 Aug 10, 2021	BUY	$144.0 - $179.73 $5,760 - $7,189	40 Added 3.13%	1,318 $213,000
Q1 2021 May 17, 2021	BUY	$158.92 - $221.61 $3,496 - $4,875	22 Added 1.75%	1,278 $219,000
Q4 2020 Feb 12, 2021	SELL	$162.05 - $240.27 $285,856 - $423,836	-1,764 Reduced 58.41%	1,256 $276,000
Q3 2020 Nov 13, 2020	SELL	$113.26 - $167.27 $45,757 - $67,577	-404 Reduced 11.8%	3,020 $501,000
Q2 2020 Aug 05, 2020	BUY	$72.01 - $120.39 $15,338 - $25,643	213 Added 6.63%	3,424 $391,000
Q1 2020 May 14, 2020	SELL	$69.78 - $116.21 $32,587 - $54,270	-467 Reduced 12.7%	3,211 $247,000
Q4 2019 Feb 13, 2020	BUY	$70.76 - $128.86 $69,910 - $127,313	988 Added 36.73%	3,678 $474,000
Q3 2019 Nov 12, 2019	SELL	$77.91 - $109.6 $11,608 - $16,330	-149 Reduced 5.25%	2,690 $210,000
Q2 2019 Aug 13, 2019	SELL	$59.49 - $104.71 $218,149 - $383,971	-3,667 Reduced 56.36%	2,839 $292,000
Q1 2019 May 14, 2019	SELL	$43.65 - $78.95 $33,959 - $61,423	-778 Reduced 10.68%	6,506 $477,000
Q4 2018 Feb 05, 2019	SELL	$32.0 - $47.43 $73,312 - $108,662	-2,291 Reduced 23.93%	7,284 $309,000
Q3 2018 Nov 14, 2018	SELL	$47.1 - $62.7 $322,823 - $429,745	-6,854 Reduced 41.72%	9,575 $451,000
Q2 2018 Aug 10, 2018	SELL	$26.05 - $52.4 $695,717 - $1.4 Million	-26,707 Reduced 61.91%	16,429 $810,000
Q1 2018 May 14, 2018	BUY	$17.2 - $34.95 $401,620 - $816,082	23,350 Added 118.01%	43,136 $1.32 Million
Q4 2017 Feb 14, 2018	BUY	$12.65 - $19.0 $250,292 - $375,934	19,786	19,786 $361,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account